US Patent Issued to BEIJING CHENGYI INVESTMENT on Aug. 12 for "Use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in preparation of medicine for eye injuries" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,573, issued on Aug. 12, was assigned to BEIJING CHENGYI INVESTMENT Co. LTD. (Beijing).

"Use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in preparation of medicine for eye injuries" was invented by Hao Wang (Beijing) and Xuexiang Cheng (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is the use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in the preparation of a medicine for eye injuries, wherein same falls within the technical field of medicines. Further provided is the use of luteolin-7-O-glucoside and/or luteolin-7-O-glucuronide in the preparation of a medicine for treating eye injuries caused by blue light. An i...